Accordingly, screening for aberrant IRX gene activities in acute myeloid leukemia (AML) revealed overexpression of IRX1, IRX3 and IRX5 in subsets of patients, identifying these genes as oncogenes for this type of malignancy [30]. The gene discussed is IRX1; the disease is acute myeloid leukemia.